Patent 7115617 was granted and assigned to Amgen on October, 2006 by the United States Patent and Trademark Office.
The invention encompasses compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions, uses and methods for prophylaxis and treatment of cancer.